NEW YORK (GenomeWeb News) – MDxHealth and Ghent University announced today that they have formed a new epigenetics research center to accelerate innovations in personalized medicine.

The partners have established NXTGNT, a Center in Pharmaco (Epi)genomics, at Ghent University within its laboratory of pharmaceutical biotechnology. The Center, which will be fully operational as of Dec. 1, will bring together disease-centered basic researchers, clinical validation teams, and bioinformaticians to apply epigenomics technology to personalized medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.